 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Cost Effectiveness Study Shows Sequencing-Based T21 Test Leads to Better Clinical Outcomes
May 02, 2012
Cost Effectiveness Study Shows Sequencing-Based T21 Test Leads to Better Clinical Outcomes
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- As Rivals Vie for Share of Noninvasive Trisomy Testing Market, Physicians See Value for Screening
July 3, 2012 / Clinical Sequencing News - As MaterniT21 Drives Spike in Diagnostic Revenue, Sequenom Predicts 25K Tests Sold in 2012
March 14, 2012 / Clinical Sequencing News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News - Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 6, 2012 / Clinical Sequencing News - Sequenom Plans Sample-Prep Automation, Increased Multiplexing to Double MaterniT21 Capacity
May 9, 2012 / Clinical Sequencing News